Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 14, 2021; 27(34): 5630-5665
Published online Sep 14, 2021. doi: 10.3748/wjg.v27.i34.5630
Published online Sep 14, 2021. doi: 10.3748/wjg.v27.i34.5630
Energy/Nutrient | Criteria | Recommendation |
Estimation of REE | All individuals with COVID-19 | Estimation by indirect calorimetry |
Prediction equations | ||
Calories | Normal oral diets | 1500-2000 kcals/d |
Increase 400-500 kcals in stress or infection crisis | ||
Polymorbid, old patients > 65 yr | 27 kcals/kg Bw/day | |
Low weight, older patients | 30 kcals/kg Bw/day | |
Malnourish chronic patients and muscle depletion | 30-35 kcals/kg Bw/day | |
-Patients with COVID-19 outside ICU | ONS with low oral intolerance: | |
150-400 kcals/service | ||
70-100 g protein/service | ||
Carbohydrates, fiber, PUFAs, vitamins, minerals, probiotics | ||
Consuming for a month | ||
Protein | Normal individuals (prevent loss and muscle mass) | 1 g/kg Bw/day |
70-100 g/d | ||
Form animal (milk, yogurt, meat, fish, chicken, cheese) and vegetable sources (beans, soy, nuts, peas) | ||
Patients with liver cirrhosis sarcopenic | 1.2-1.5 g/kg Bw/day | |
Obese sarcopenic | Oral supplementation of BCAA 0.20-0.25 g/kg Bw/day or 30 g/d | |
Glutamine and arginine supplementation | ||
Carbohydrates/fat | Patients with COVID-19 without respiratory impairment | Ratio 70:30 carbohydrates/fat |
Medium and low glycemic | ||
Fiber 25-30 g/d | ||
PUFAs: DHA, EPA, ALA | ||
Patients with ventilator support | Ratio 50:50 carbohydrates/fat | |
Vitamins | All individuals with COVID-19 | A, C, D, E, folate, B6 and B12 (monitoring in patients with liver abnormalities) |
Minerals | All individuals with COVID-19 | Zinc, copper, selenium (monitoring in patients with liver abnormalities) |
Critically ill patients | EN after 24-36 h. after ICU admission | |
Initiate with trophic low-dose (10-20 mL/h.) | ||
Polymeric formula: 15-20 kcals/kg Bw and 1.2-2.0 g/kg Bw/day of protein vitamins, minerals, fiber, probiotics | ||
Provide 70%-80% needs in over 1 wk | ||
Sever obese patients BMI > 50 | Energy 22-25 kcals/kg IBW | |
Protein 2 g/kg per day (Class I, II) or 2.5 g/kg IBW/day of (Class III) | ||
Vitamins, minerals, fiber, probiotics | ||
Gastric intolerance individuals | Use prokinetics | |
Post-pyloric feeding in persistence intolerance or at high risk of aspiration | ||
Patients with no GI feasible | PN recommended | |
Poor nutrition status | Limit the use of omega-6 soy-based ILE during first week | |
Prolonged stay at ICU | Mixture of lipids such as olive oil based ILE or SMOF (soy, medium chain triglycerides, olive oil, fish oil) |
- Citation: Vargas-Mendoza N, García-Machorro J, Angeles-Valencia M, Martínez-Archundia M, Madrigal-Santillán EO, Morales-González Á, Anguiano-Robledo L, Morales-González JA. Liver disorders in COVID-19, nutritional approaches and the use of phytochemicals. World J Gastroenterol 2021; 27(34): 5630-5665
- URL: https://www.wjgnet.com/1007-9327/full/v27/i34/5630.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i34.5630